Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)
Hong Kong · Delayed Price · Currency is HKD 16.09
0.00 (0.00%)
Aug 21, 2026, 4:08 PM HKT
HKG:2659 Market Cap
HKG:2659 has a market cap or net worth of 5.25 billion as of August 21, 2026.
Market Cap
5.25B
Enterprise Value
4.21B
Revenue
54.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.09
ChartMarket Cap Chart
Since December 10, 2025, HKG:2659's market cap has decreased from 20.54B to 5.25B, a decrease of -74.46%. That is a compound annual growth rate of -85.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 5.25B | -79.25% |
| Dec 31, 2025 | 25.28B | 23.10% |
| Dec 10, 2025 | 20.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LongBio Pharma (Suzhou) | 7.81B |
| Lepu Biopharma | 7.65B |
| Shanghai Haohai Biological Technology | 7.43B |
| Abbisko Cayman | 7.31B |
| CK Life Sciences Int'l., (Holdings) | 5.24B |
| Ocumension Therapeutics | 4.25B |
| TransThera Sciences (Nanjing) | 4.14B |
| Jacobio Pharmaceuticals Group | 3.98B |